Logos Pharma is a technology-driven business supported by R&D and F&D departments, combined with well-equipped laboratories. We hire industry’s most talented personnel.
The objectives of R&D department is to enhance the consistency of formulations, developing new formulations, creating newer and novel dosage types, cost reduction etc. Logos has fully equipped Analytical development lab, Pilot scale plant for technology transfers and state of the art microbiological testing facility. Our facility has technical collaboration with various CRO’s (Clinical Research Organizations) to conduct various BA/BE studies and Clinical trials.
It is not just the latest molecules that we work on at the R&D centre, we are trying to make the current ones stronger. When it comes to patient compliance, improved bioavailability, patient comfort and doctor trust, we focus on simple things that make a world of difference and represent the ground we cover for patients along with our customers.
The objectives of R&D department is to enhance the consistency of formulations, developing new formulations, creating newer and novel dosage types, cost reduction etc. Logos has fully equipped Analytical development lab, Pilot scale plant for technology transfers and state of the art microbiological testing facility. Our facility has technical collaboration with various CRO’s (Clinical Research Organizations) to conduct various BA/BE studies and Clinical trials.
It is not just the latest molecules that we work on at the R&D centre, we are trying to make the current ones stronger. When it comes to patient compliance, improved bioavailability, patient comfort and doctor trust, we focus on simple things that make a world of difference and represent the ground we cover for patients along with our customers.
Some salient features are as below :
- Pre formulation studies.
- Lab / pilot scale development and stability studies.
- Scale up for process optimization / validation.
- Technology transfer of new products.
- Dossier assistance for regulatory affairs.
- Working on novel molecules and novel dosage form such as Tablet in capsule technology, modified release oral dosage forms.
- Introduction of the Novel molecules such as Bempedoic acid tablets 180 mg, Favipiravir tablets 200 mg, 400 mg, 800 mg and their combikit, Molnupiravir tablets and many more.
- We are expecting to launch FDC of Bempedoic acid and Ezetimibe tablets, Combikit of Nirmatrelvir and Ritonavir soon along with many more new combinations in diabetics and neuro range.
- To conduct stability studies of developmental batches in various conditions.
- Complete documentation support to the manufacturing unit.
- Preparation of Tech Transfer documents & Validation protocols.
- Support to Manufacturing unit to conduct Scale up / Validation batches.